Balázs Cséke
YOU?
Author Swipe
View article: Trick or Treat(ment): Should We Still Fear Reperfusion Therapy in Anticoagulated Stroke Patients?—Comparable 90-Day Outcomes in a Propensity-Score-Matched Registry Study
Trick or Treat(ment): Should We Still Fear Reperfusion Therapy in Anticoagulated Stroke Patients?—Comparable 90-Day Outcomes in a Propensity-Score-Matched Registry Study Open
Background: The management of acute ischemic stroke (AIS) in anticoagulated patients presents a clinical challenge, as concerns about safety and efficacy often limit access to recanalization therapies. Despite the widespread use of direct …
View article: Putting DOAC Doubts to Bed(Side): Preliminary Evidence of Comparable Functional Outcomes in Anticoagulated and Non-Anticoagulated Stroke Patients Using Point-of-Care ClotPro® Testing
Putting DOAC Doubts to Bed(Side): Preliminary Evidence of Comparable Functional Outcomes in Anticoagulated and Non-Anticoagulated Stroke Patients Using Point-of-Care ClotPro® Testing Open
Background/Objectives: Direct oral anticoagulants (DOACs) are now the guideline-recommended alternative to vitamin K antagonists (VKAs) for long-term anticoagulation in patients with non-valvular atrial fibrillation. However, accurately as…
View article: Viscoelastic Point-of-Care Testing (ClotPro®) to Guide Intravenous Thrombolysis in Acute Ischemic Stroke Patients on DOACs: Replacing History with Hemostasis in a Proof-of-Concept Study
Viscoelastic Point-of-Care Testing (ClotPro®) to Guide Intravenous Thrombolysis in Acute Ischemic Stroke Patients on DOACs: Replacing History with Hemostasis in a Proof-of-Concept Study Open
Background: Administering intravenous thrombolysis (IVT) in patients with acute ischemic stroke (AIS) on direct oral anticoagulants (DOACs) remains a clinical challenge. Current guidelines restrict IVT within 48 h of DOAC intake unless ant…
View article: Viscoelastic Point-of-Care Testing (ClotPro®) to Guide Intravenous Thrombolysis in Acute Ischemic Stroke Patients on DOACs: Replacing History with Hemostasis in a Proof-of-Concept Study
Viscoelastic Point-of-Care Testing (ClotPro®) to Guide Intravenous Thrombolysis in Acute Ischemic Stroke Patients on DOACs: Replacing History with Hemostasis in a Proof-of-Concept Study Open
Background: Administering intravenous thrombolysis (IVT) in patients with acute ischemic stroke (AIS) on direct oral anticoagulants (DOACs) remains a clinical challenge. Current guidelines restrict IVT within 48 hours of DOAC intake unless…
View article: Trick or Treat(ment): Should We Still Fear Reperfusion Therapy in Anticoagulated Stroke Patients?
Trick or Treat(ment): Should We Still Fear Reperfusion Therapy in Anticoagulated Stroke Patients? Open
Background: The management of acute ischemic stroke (AIS) in anticoagulated patients presents a clinical challenge, as concerns about safety and efficacy often limit access to recanalization therapies. Despite the widespread use of direct …
View article: Putting DOAC Doubts to Bed(side): Point-of-Care ClotPro® Testing Confirms Comparable Functional Outcomes in Anticoagulated and Non-Anticoagulated Stroke Patients
Putting DOAC Doubts to Bed(side): Point-of-Care ClotPro® Testing Confirms Comparable Functional Outcomes in Anticoagulated and Non-Anticoagulated Stroke Patients Open
Background Direct oral anticoagulants (DOACs) are now the guideline-recommended alternative to vitamin K antagonists (VKAs) for long-term anticoagulation. However, accurately assessing their impact on ischemic stroke outcomes remains chall…
View article: Shifting Outcomes: Superior Functional Recovery in Embolic Stroke of Undetermined Source Compared to Cardioembolic Stroke
Shifting Outcomes: Superior Functional Recovery in Embolic Stroke of Undetermined Source Compared to Cardioembolic Stroke Open
Background/Objectives: An embolic stroke of undetermined source (ESUS) is a subtype of ischemic stroke characterized by a non-lacunar infarct in the absence of a clearly identifiable embolic source, despite comprehensive diagnostic evaluat…
View article: Pre-Admission Antiplatelet Therapy in Cryptogenic Stroke: A Double-Edged Sword
Pre-Admission Antiplatelet Therapy in Cryptogenic Stroke: A Double-Edged Sword Open
Background: Cryptogenic stroke, a challenging subtype of acute ischemic stroke (AIS), is characterized by the absence of an identifiable etiology despite thorough diagnostic assessment. The role of pre-admission antiplatelet therapy (APT) …
View article: A Match Made Unequal: Impact of Oral Anticoagulants on Stroke Outcomes Following Propensity Score Matching
A Match Made Unequal: Impact of Oral Anticoagulants on Stroke Outcomes Following Propensity Score Matching Open
Background/Objectives: Oral anticoagulants (OACs) are commonly used for stroke prevention in patients with atrial fibrillation (AF), but their impact on long-term outcomes following acute ischemic stroke (AIS) remains uncertain. This study…
View article: Shifting Outcomes: Superior Functional Recovery in Embolic Stroke of Undetermined Source Compared to Cardioembolic Stroke
Shifting Outcomes: Superior Functional Recovery in Embolic Stroke of Undetermined Source Compared to Cardioembolic Stroke Open
Background/Objectives: Embolic Stroke of Undetermined Source (ESUS) is a subtype of ischemic stroke characterized by a non-lacunar infarct in the absence of a clearly identifiable embolic source, despite comprehensive diagnostic evaluation…
View article: Stroke-SCORE: Personalizing Acute Ischemic Stroke Treatment to Improve Patient Outcomes
Stroke-SCORE: Personalizing Acute Ischemic Stroke Treatment to Improve Patient Outcomes Open
Background/Objectives: Acute ischemic stroke (AIS) is a leading cause of disability and mortality worldwide. Despite advances in interventions such as thrombolysis (TL) and mechanical thrombectomy (MT), current treatment protocols remain l…
View article: Pre-Admission Antiplatelet Therapy in Cryptogenic Stroke: A Double-Edged Sword
Pre-Admission Antiplatelet Therapy in Cryptogenic Stroke: A Double-Edged Sword Open
Background/Objectives: Cryptogenic stroke, a challenging subtype of acute ischemic stroke (AIS), is characterized by the absence of an identifiable etiology despite thorough diagnostic assessment. The role of pre-admission antiplatelet the…
View article: Subsequent Acute Ischemic Stroke in a Patient with Monocular Vision Loss Associated with Isolated Internal Carotid Artery Occlusion: A Case Report
Subsequent Acute Ischemic Stroke in a Patient with Monocular Vision Loss Associated with Isolated Internal Carotid Artery Occlusion: A Case Report Open
Background/Objectives: Acute retinal ischemia, including central retinal artery occlusion (CRAO), is recognized as a stroke equivalent by the American Heart Association/American Stroke Association (AHA/ASA), necessitating immediate multidi…
View article: Stroke-SCORE: Personalizing Acute Ischemic Stroke Treatment to Improve Patient Outcomes
Stroke-SCORE: Personalizing Acute Ischemic Stroke Treatment to Improve Patient Outcomes Open
Background/Objectives: Acute ischemic stroke (AIS) is a leading cause of disability and mortality worldwide. Despite advances in interventions such as thrombolysis (TL) and mechanical thrombectomy (MT), current treatment protocols remain l…
View article: Beyond Anticoagulation: Limitations of Oral Anticoagulants in Preventing Stroke Recurrence in Atrial Fibrillation
Beyond Anticoagulation: Limitations of Oral Anticoagulants in Preventing Stroke Recurrence in Atrial Fibrillation Open
Background/Objectives: Despite the widespread use of oral anticoagulants (OACs), acute ischemic stroke (AIS) remains a significant risk for patients with atrial fibrillation (AF). The real-world effectiveness of OACs in preventing recurren…
View article: Beyond Anticoagulation: Limitations of Oral Anticoagulants in Preventing Stroke Recurrence in Atrial Fibrillation
Beyond Anticoagulation: Limitations of Oral Anticoagulants in Preventing Stroke Recurrence in Atrial Fibrillation Open
Background/Objectives: Despite the widespread use of oral anticoagulants (OACs), acute ischemic stroke (AIS) remains a significant risk for patients with atrial fibrillation (AF). The real-world effectiveness of OACs in preventing recurren…
View article: Bridging the Gap: Improving Acute Ischemic Stroke Outcomes with Intravenous Thrombolysis Prior to Mechanical Thrombectomy
Bridging the Gap: Improving Acute Ischemic Stroke Outcomes with Intravenous Thrombolysis Prior to Mechanical Thrombectomy Open
Background/Objectives: Current guidelines recommend intravenous thrombolysis (IVT) followed by mechanical thrombectomy (MT) for patients with acute ischemic stroke (AIS) caused by large vessel occlusion (LVO). This combined approach, known…
View article: Bridging the Gap: Improving Acute Ischemic Stroke Outcomes with Intravenous Thrombolysis Prior to Mechanical Thrombectomy
Bridging the Gap: Improving Acute Ischemic Stroke Outcomes with Intravenous Thrombolysis Prior to Mechanical Thrombectomy Open
Background/Objectives: Current guidelines recommend intravenous thrombolysis (IVT) followed by mechanical thrombectomy (MT) for patients with acute ischemic stroke (AIS) caused by large vessel occlusion (LVO). This combined approach, known…
View article: Subsequent acute ischemic stroke in a patient with monocular vision loss associated with isolated internal carotid artery occlusion: a case report
Subsequent acute ischemic stroke in a patient with monocular vision loss associated with isolated internal carotid artery occlusion: a case report Open
Background Despite a growing body of evidence and ongoing clinical trials assessing the efficacy of reperfusion therapies in the acute phase, reliable systems capable of rapidly identifying patients with central retinal artery occlusion (C…